CAS 1798787-27-5

Formel: C23H29N7O2

InChl: InChI=1S/C23H29N7O2/c1-15(2)32-20-13-30(14-20)23(31)25-10-18-6-5-17(9-16(18)3)21-7-8-24-22(28-21)27-19-11-26-29(4)12-19/h5-9,11-12,15,20H,10,13-14H2,1-4H3,(H,25,31)(H,24,27,28)

InChI Key: BMWMKGNVAMXXCH-UHFFFAOYSA-N

SMILES: CC1=C(C=CC(=C1)C2=NC(=NC=C2)NC3=CN(N=C3)C)CNC(=O)N4CC(C4)OC(C)C

BIIB068

CAS: 1798787-27-5

BIIB068

Formel: C₂₃H₂₉N₇O₂

Reinheit: ≥95%

Molekulargewicht: 435.52

Ref: 54-BUP07616

BIIB068

CAS: 1798787-27-5

BIIB068 is an selective, reversible and orally active BTK inhibitor (IC50 = 1 nM, Kd = 0.3 nM). BIIB068 is 400 times more selective for BTK than other kinases.

Formel: C₂₃H₂₉N₇O₂

Reinheit: 97.98%

Farbe und Form: White Solid

Molekulargewicht: 435.5221

Ref: TM-T9192

BIIB068

CAS: 1798787-27-5

3-Isopropoxy-N-(2-methyl-4-(2-((1-methyl-1H-pyrazol-4-yl)amino)pyrimidin-4-yl)benzyl)azetidine-1-carboxamide

Formel: C₂₃H₂₉N₇O₂

Reinheit: 99%

Molekulargewicht: 435.52

Ref: IN-DG01480630

BIIB068

CAS: 1798787-27-5

BIIB068 is a peptide that is used as a research tool to study the activation of ion channels. It is an activator of Kv1.2 and Kv4.3 potassium channels, and has been shown to inhibit calcium-activated potassium channels. It has also been shown to be an inhibitor of protein interactions with the receptor D2S2-5. BIIB068 binds to the ligand binding site on the D2S2-5 receptor, preventing other ligands from binding, which leads to its pharmacological effects. This peptide contains 1798787-27-5, which is its CAS number.

Formel: C₂₃H₂₉N₇O₂

Reinheit: Min. 95%

Molekulargewicht: 435.5 g/mol

Ref: 3D-YWC78727